IP Library Granted Patent US 12,343,360
Granted Patent B2
US 12,343,360 · App. 17/150,501 · Granted Jul 1, 2025

Methods and compositions for microbial engraftment

Inventors: John S. Eid (San Francisco, CA); Colleen Cutcliffe (Menlo Park, CA); James H. Bullard (San Francisco, CA); Nicholas Justice (San Francisco, CA); Jessica Gines (San Francisco, CA); Surabhi Tyagi (San Francisco, CA); Marcus F. Schicklberger (Richmond, CA); Andrew T. Cheng (San Mateo, CA); Paul McMurdie (San Francisco, CA); Christian Sieber (San Francisco, CA)
Assignee: Pendulum Therapeutics Inc
A61K35/74A61K38/28A61P37/06
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,343,360
App. No.
17/150,501
Granted
Jul 1, 2025
Kind
B2
Abstract

The disclosure provides compositions and methods for therapeutic administration of the compositions to treat comorbidities associated with gut dysbiosis. The disclosure also provides compositions and methods for increasing engraftment of administered microbes. The disclosure also provides methods for stool sample collection.

Claims (9)

1. A method of increasing engraftment of Eubacterium hallii in the gut of a mammalian subject, the method comprising:

administering to the gut of the mammalian subject Eubacterium hallii and Akkermansia muciniphila ; and

measuring increased engraftment of Eubacterium hallii in the gut of the subject.

2. The method according to claim 1 , wherein the engraftment is increased by at least about 5%.

3. The method according to claim 1 , wherein the increased engraftment is measured by measuring an increased relative abundance of the at least one butyrate producing microbe Eubacterium hallii in the subject for more than 4 weeks after administration has ceased.

4. The method according to claim 1 , wherein the Eubacterium hallii only engrafts in a presence of Akkermansia muciniphila.

5. The method according to claim 1 , wherein the Eubacterium hallii and Akkermansia muciniphila are formulated for oral delivery.

6. The method according to claim 1 , further comprising administering a prebiotic.

7. The method according to claim 6 , wherein the prebiotic is inulin.

Assignments (2)
SECURITY INTEREST Recorded Jan 18, 2022
From: PENDULUM THERAPEUTICS, INC.
To: TRINITY CAPITAL INC.
Reel/Frame 058678/0276 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 15, 2021
From: EID, JOHN S.; CUTCLIFFE, COLLEEN; BULLARD, JAMES H.; JUSTICE, NICHOLAS; GINES, JESSICA; TYAGI, SURABHI; SCHICKLBERGER, MARCUS F.; CHENG, ANDREW T.; MCMURDIE, PAUL; SIEBER, CHRISTIAN
To: PENDULUM THERAPEUTICS, INC.
Reel/Frame 054936/0724 →